Oral Health Group

Straumann took an axe,and gave Nobel forty whacks

2011-12-12 14:23:55

April 27, 2011
by ken

From Reuters – April 28, 2011 – by Silke Koltrowitz

Nobel Biocare expects market growth in 2011

ZURICH, April 28 (Reuters) – Swiss dental implant maker
Nobel Biocare (NOBN.VX) said it expected to return to mid
single-digit growth, in line with the market, by mid-year, when
posting a weaker-than-expected first-quarter net profit.

My Implant

Image by fe_cavallo via Flickr

Nobel Biocare, knocked off top spot in the dental implant
market by Swiss rival Straumann (STMN.S) last year, said on
Thursday net profit fell two thirds to 12.9 million euros ($18.9

The group booked a one-off currency gain of 30.1 million
euros in the 2010 period.

Read entire article

Enhanced by Zemanta

Print this page


Have your say:

Your email address will not be published.